Old Web
English
Sign In
Acemap
>
authorDetail
>
Robert Lawatscheck
Robert Lawatscheck
Bayer
Medicine
Placebo
Amikacin
Phases of clinical research
Intravenous therapy
3
Papers
37
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Hyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD Trial.
2021
Journal of The American Society of Nephrology
Rajiv Agarwal
Amer Joseph
Stefan D. Anker
Gerasimos Filippatos
Peter Rossing
Luis M. Ruilope
Bertram Pitt
Peter Kolkhof
Charlie Scott
Robert Lawatscheck
Daniel Wilson
George L. Bakris
Show All
Source
Cite
Save
Citations (0)
XATOA: Rationale and design of a prospective registry study to assess rivaroxaban 2.5 mg twice daily plus aspirin for prevention of atherothrombotic events in coronary artery disease, peripheral artery disease, or both
2020
American Heart Journal
Keith A.A. Fox
Sonia S. Anand
Victor Aboyans
Martin R. Cowie
E. Sebastian Debus
Uwe Zeymer
Danja Monje
Kai Vogtländer
Robert Lawatscheck
Show All
Source
Cite
Save
Citations (7)
Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial
2019
Lancet Infectious Diseases
Michael S. Niederman
Jeff Alder
Matteo Bassetti
Francis Boateng
Bin Cao
K Corkery
Rajiv Dhand
Keith S Kaye
Robert Lawatscheck
Patrick McLeroth
David P. Nicolau
Chen Wang
G. Christopher Wood
Richard G. Wunderink
Jean Chastre
Show All
Source
Cite
Save
Citations (30)
1